[Taylor&Francis] Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis

lulw Post time 2022-11-25 03:34:35 | Show all posts |Read mode
Reward10points

journal£ºImmunopharmacology and Immunotoxicology

Authors£ºTong Liu; Duo Liu; Yao Jin; Mei Dong

Published date£º--

DOI£º10.1080/08923973.2022.2090956

Article link£ºhttp://dx.doi.org/10.1080/08923973.2022.2090956

Article Source£ºInforma UK Limited¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time 2022-11-25 03:34:36 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Junior Member
  • post

  • reply

  • points

    40

Same Category

Latest Reply



Return to the list